RecruitingPhase 3

An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease

Uganda2,400 participantsStarted 2022-05-04

Plain-language summary

A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \>18 years * CD4\<200 cells/µL * Ability and willingness to give informed consent for the enhanced package of care arm. Exclusion Criteria: * Known virologic suppression (viral load \<1000 copies/mL) within prior 3 months * Cannot or unlikely to attend regular clinic visits

What they're measuring

24-week survival with retention in care

Timeframe: 24 weeks

Trial details

NCT IDNCT05085171

SponsorMakerere University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-03-01

Contact for this trial

Radha Rajasingham, MD

612 626-8171 radha@umn.edu

View on ClinicalTrials.gov More The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease trials